Vanda Pharmaceuticals (VNDA) Profit After Tax: 2010-2025
Historic Profit After Tax for Vanda Pharmaceuticals (VNDA) over the last 16 years, with Sep 2025 value amounting to -$22.6 million.
- Vanda Pharmaceuticals' Profit After Tax fell 324.23% to -$22.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$84.2 million, marking a year-over-year decrease of 413.78%. This contributed to the annual value of -$18.9 million for FY2024, which is 853.29% down from last year.
- Vanda Pharmaceuticals' Profit After Tax amounted to -$22.6 million in Q3 2025, which was up 16.98% from -$27.2 million recorded in Q2 2025.
- Vanda Pharmaceuticals' Profit After Tax's 5-year high stood at $9.7 million during Q2 2021, with a 5-year trough of -$29.5 million in Q1 2025.
- For the 3-year period, Vanda Pharmaceuticals' Profit After Tax averaged around -$8.7 million, with its median value being -$4.5 million (2024).
- In the last 5 years, Vanda Pharmaceuticals' Profit After Tax soared by 1,679.84% in 2021 and then plummeted by 3,986.13% in 2024.
- Quarterly analysis of 5 years shows Vanda Pharmaceuticals' Profit After Tax stood at $7.1 million in 2021, then fell by 3.07% to $6.9 million in 2022, then slumped by 134.98% to -$2.4 million in 2023, then tumbled by 104.67% to -$4.9 million in 2024, then slumped by 324.23% to -$22.6 million in 2025.
- Its last three reported values are -$22.6 million in Q3 2025, -$27.2 million for Q2 2025, and -$29.5 million during Q1 2025.